Table 1 Participant characteristics.

From: Evaluation of telehealth support in an integrated respiratory clinic

Cohort

Asthma

COPD

Total

 

Telehealth

Control

Telehealth

Control

Telehealth

Control

N

17

12

17

16

34

28

Demographics

      

Age (years)

62 [43,68]

64 [56.3, 70.3]

65 [59,70]

69.5 [66, 72.5]

64 [57,70]

68.5 [61.8, 72]

Male (%)

7 (41.2)

1 (8.33)

8 (47.1)

8 (50.0)

15 (44.1)

9 (32.1)

BMI kg/m2

30.1 [27.3, 33.6]

30.4 [25.2, 33.5]

24.9 [22.6. 31.7]

26.4 [23.4, 30.1]

29.4 [24.5, 33.6]

27.8 [24.6, 32.6]

Lung function

      

FEV1 % predicted

70.4 ± 22.8

79.5 ± 17.4

54.4 ± 16.0

43.1 ± 22.3

62.1 ± 21.1

58.5 ± 27.2

FeNO ppb

17 [11.5, 45]

16 [9, 30.5]

9 [6,12]

18.5 [12, 27.8]

12 [9,25]

16 [9.5, 28.5]

Smoking status

      

Current smoker (%)

5 (29.4)

5 (41.7)

10 (58.8)

6 (37.5)

15 (44.1)

11 (39.3)

Ex-smoker (%)

9 (52.9)

6 (50.0)

7 (41.2)

10 (62.5)

16 (47.1)

16 (57.1)

Never smoker (%)

3 (17.6)

1 (8.3)

0

0

3 (8.8)

1 (3.6)

Comorbidities

      

≥1 (%)

10 (58.8)

7 (58.3)

14 (82.4)

15 (93.8)

24 (70.6)

22 (78.6)

Cardiovascular (%)

7 (41.2)

5 (41.7)

5 (29.4)

9 (56.3)

12 (35.3)

14 (50)

Gastrointestinal (%)

6 (35.3)

2 (16.7)

5 (29.4)

6 (37.5)

11 (32.4)

8 (28.6)

Diabetes (%)

6 (35.3)

1 (8.3)

4 (23.5)

5 (31.3)

10 (29.4)

6 (21.4)

  1. Values are median [Q1, Q3], number (%) or mean ± SD
  2. BMI body mass index, FEV1 forced expiratory volume in one second, FeNO Fraction of exhaled nitric oxide.